VCA (WOOF) has an average broker rating of 1.67, which is interpreted as a Buy, as rated by 6 equity analysts. Nonetheless, 3 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. 2 other analysts advise a Buy. Nevertheless, the majority of 1 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 2, which is also a Buy.
VCA (WOOF) : Average target price received by VCA (WOOF) is $72.6 with an expected standard deviation of $7.16. The most aggressive target on the stock is $80, whereas the most downbeat target is $62. 5 financial analysts are currently covering the stock.
For the current week, the company shares have a recommendation consensus of Buy. VCA (NASDAQ:WOOF): The stock was completely flat for the day, closing at $72.59 on Thursday. The flat closing masks the intraday volatility in the stock. After opening at $72.80, the stock touched an intraday high of $73.13 and a low of $72.56. Neither the bulls nor the bears asserted their supremacy at close, due to which the stock closed completely flat. The stock previously closed at $72.59. The total trading volume on Thursday was 643,368.
In a related news, The Securities and Exchange Commission has divulged that Chickering John B Jr, director of Vca Inc, had unloaded 2,302 shares at an average price of $70.85 in a transaction dated on August 4, 2016. The total value of the transaction was worth $163,097.
VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Companys animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Companys communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Companys network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.